HIF1A, hypoxia inducible factor 1 subunit alpha, 3091

N. diseases: 1044; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric transcription factor that regulates transcriptional activation of several genes that are responsive to oxygen lack, including erythropoietin, vascular endothelial growth factor, various glycolytic enzymes and the GLUT-1 glucose transporter. 12062197 2002
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Hypoxia stimulates hypoxia-inducible factor-1alpha (HIF-1alpha), a transcriptional activator of VEGF. 12401798 2002
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Hypoxia-dependent up regulation of HIF-1alpha transcriptional activity is critical for survival of hypoxic chondrocyte, and it shapes up the fetal growth plate by inhibiting chondrocyte proliferation, increasing matrix accumulation and probably modulating cell size. 16144691 2006
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Hypoxia-inducible factors HIF-1 and HIF-2 are oxygen-sensitive basic helix-loop-helix transcription factors, which regulate biological processes that facilitate both oxygen delivery and cellular adaptation to oxygen deprivation. 16554418 2006
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN A role for hypoxia-inducible factor (HIF)-1 was suggested by the increase in HIF-1alpha as a result of hypoxia and by the increase in GLUT1 expression following treatment of BeWo with MG-132, a proteasomal inhibitor that increases HIF-1 levels. 17442736 2007
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Alltogether, our data indicate that HIF-1alpha and hypoxia play a crucial role for DC activation in inflammatory states, which is highly dependent on glycolysis even in the presence of oxygen. 18354193 2008
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN As a result, Zn chelation causes the accumulation of nonfunctional HIF-1alpha protein in both normoxia and hypoxia. 16579968 2006
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN As GLUT-1 was induced via Hif-1alpha under hypoxia in A204 RMS and A673 ES, these findings suggest that the Hif-1alpha-mediated increase in glucose uptake plays an important role in conferring apoptosis resistance. 17043658 2007
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. 14699081 2004
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Cell density also correlated with increased staining for reductively activated pimonidazole (a marker for hypoxia), as well as with increased levels of the HIF-1alpha subunit and HIF transcriptional activity as determined by immunocytochemistry, Western blot, and luciferase reporter assays. 17289019 2007
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Cellular response to hypoxia involves signaling via Smad proteins. 12411310 2003
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Chromatin immunoprecipitation assay demonstrated that HIF-1 alpha directly bound to this region under normoxia, and this binding activity was significantly enhanced under hypoxia. 18339685 2008
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Chromatin immunoprecipitation identified a previously unappreciated binding site for the hypoxia inducible factor-1 (HIF-1), and promoter studies established its relevance by loss of repression following point mutation. 18779379 2009
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Dimethyloxallyl glycine, a stabilizer of hypoxia-inducible factor 1alpha (HIF1alpha), mimicked the hypoxia-mediated upregulation of visfatin, and YC1, an inhibitor of HIF1 cancelled the hypoxia-induced upregulation of visfatin mRNA. 16970912 2006
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN During hypoxia in A549 cells, HIF-1alpha promotes activity of the glycolysis pathway and decreases the pH of the culture medium, resulting in increased cellular apoptosis. 16438736 2006
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Endogenous hypoxia markers: case not proven! 18290322 2008
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Enhanced sensitivity of protein kinase B/Akt to insulin in hypoxia is independent of HIF1alpha and promotes cell viability. 17544543 2007
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Experiments were carried out on human ovarian carcinoma cells in four series: (1) control [Normoxia (5% CO2 in air), no treatment], (2) hypoxia (1% O2, 5% CO2, and 94% N2 for 48 h), (3) treatment with ASO targeted to HIF1A (48 h), and (4) combined action of hypoxia and ASO. 15832512 2005
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN First, HIF-1 controls the expression of gene products that stimulate angiogenesis, such as vascular endothelial growth factor, and promote metabolic adaptation to hypoxia, such as glucose transporters and glycolytic enzymes, thus providing a molecular basis for involvement of HIF-1 in tumor growth and angiogenesis. 11868612 2002
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Gel shift assays with a (32)P-labeled leptin promoter -116/HRE probe and nuclear extracts from hypoxia-treated cells indicated binding of the HIF1alpha/beta heterodimer, which was blocked with an excess of unlabeled -116/HRE probe or a HIF1-binding probe from the erythropoietin gene enhancer. 12084725 2002
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Here we examined the regulation of HIF-1alpha by hypoxia and nitric oxide (NO) in explants of human cerebrovascular smooth muscle cells. 14657004 2004
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 Biomarker phenotype LHGDN Here, we provide the first evidence that sphingosine kinase 1 (SphK1), an oncogenic lipid kinase balancing the intracellular level of key signaling sphingolipids, modulates the transcription factor hypoxia inducible factor 1alpha (HIF-1alpha), master regulator of hypoxia. 18922940 2008
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Herein, we identify a mechanism of increased LT in SCD and show HIF-1alpha as a hypoxia-independent target of PlGF. 18945963 2009
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN However, longer exposure (16 h) in hypoxia resulted in a decreased HIF-1alpha protein level compared with early exposure (5 h). 12764143 2003
CUI: C0003130
Disease: Anoxia
Anoxia
0.100 AlteredExpression phenotype LHGDN Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. 17525282 2007